JP2005533811A - ５−（１，３−オキサゾル−２−イル）安息香酸誘導体の調製方法 - Google Patents

５−（１，３−オキサゾル−２−イル）安息香酸誘導体の調製方法 Download PDF

Info

Publication number
JP2005533811A
JP2005533811A JP2004516055A JP2004516055A JP2005533811A JP 2005533811 A JP2005533811 A JP 2005533811A JP 2004516055 A JP2004516055 A JP 2004516055A JP 2004516055 A JP2004516055 A JP 2004516055A JP 2005533811 A JP2005533811 A JP 2005533811A
Authority
JP
Japan
Prior art keywords
alkyl
independently
aryl
heteroaryl
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004516055A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005533811A5 (cg-RX-API-DMAC7.html
Inventor
リーダー、マイケル、アール．
イムボーディノ、リック、ジェイ．
Original Assignee
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ファルマシア・アンド・アップジョン・カンパニー・エルエルシー filed Critical ファルマシア・アンド・アップジョン・カンパニー・エルエルシー
Publication of JP2005533811A publication Critical patent/JP2005533811A/ja
Publication of JP2005533811A5 publication Critical patent/JP2005533811A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
JP2004516055A 2002-06-20 2003-06-20 ５−（１，３−オキサゾル−２−イル）安息香酸誘導体の調製方法 Pending JP2005533811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39028502P 2002-06-20 2002-06-20
US45047803P 2003-02-27 2003-02-27
PCT/US2003/019585 WO2004000821A1 (en) 2002-06-20 2003-06-20 Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives

Publications (2)

Publication Number Publication Date
JP2005533811A true JP2005533811A (ja) 2005-11-10
JP2005533811A5 JP2005533811A5 (cg-RX-API-DMAC7.html) 2006-07-20

Family

ID=30003150

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004516055A Pending JP2005533811A (ja) 2002-06-20 2003-06-20 ５−（１，３−オキサゾル−２−イル）安息香酸誘導体の調製方法

Country Status (17)

Country Link
US (2) US7115747B2 (cg-RX-API-DMAC7.html)
EP (1) EP1532123B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005533811A (cg-RX-API-DMAC7.html)
CN (1) CN1324017C (cg-RX-API-DMAC7.html)
AT (1) ATE370131T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003249344A1 (cg-RX-API-DMAC7.html)
BR (1) BR0312439A (cg-RX-API-DMAC7.html)
CA (1) CA2489988A1 (cg-RX-API-DMAC7.html)
CO (1) CO5670350A2 (cg-RX-API-DMAC7.html)
DE (1) DE60315664D1 (cg-RX-API-DMAC7.html)
EA (1) EA008389B1 (cg-RX-API-DMAC7.html)
IL (1) IL165763A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04012630A (cg-RX-API-DMAC7.html)
NO (1) NO20045497L (cg-RX-API-DMAC7.html)
NZ (1) NZ537390A (cg-RX-API-DMAC7.html)
PL (1) PL374999A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004000821A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508166A (ja) * 2002-11-27 2006-03-09 イーラン ファーマスーティカルズ、インコーポレイテッド 置換尿素及びカルバメート

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200738701A (en) * 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
EP1971598A1 (en) 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) * 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US20080277393A1 (en) * 2007-05-07 2008-11-13 True Charles W Collapsible, stackable, semi-rigid universal cotainer for hazardous and non-hazardous goods
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
US7803809B2 (en) 2008-11-12 2010-09-28 Amgen Inc. Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
MX2011002705A (es) 2008-09-11 2011-09-09 Amgen Inc Compuestos con anillos espiro-triciclicos como moduladores de beta-secretasas y metodos de uso.
US8822485B2 (en) 2009-11-23 2014-09-02 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011063233A1 (en) 2009-11-23 2011-05-26 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
WO2011090911A1 (en) 2010-01-19 2011-07-28 Amgen Inc. Amino heteroaryl compounds as beta-secretase modulators and methods of use
MX2012010658A (es) 2010-03-15 2012-12-05 Amgen Inc Compuestos de anillo espiro tetraciclico como moduladores de beta-secretasa.
US8497264B2 (en) 2010-03-15 2013-07-30 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9346827B2 (en) 2011-02-07 2016-05-24 Amgen Inc. 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use
WO2013044092A1 (en) 2011-09-21 2013-03-28 Amgen Inc. Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9725469B2 (en) 2012-11-15 2017-08-08 Amgen, Inc. Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
US9462841B1 (en) 2016-03-01 2016-10-11 William Popejoy Protective headgear and shoulder pad apparatus and methods
US11272751B2 (en) 2016-03-01 2022-03-15 Nicholas Popejoy Protective headgear, impact diffusing systems and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002512A2 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
JP2005520791A (ja) * 2001-11-08 2005-07-14 イーラン ファーマスーティカルズ、インコーポレイテッド Ｎ，ｎ’−置換−１，３−ジアミノ−２−ヒドロキシプロパン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2462851A1 (en) * 2001-10-04 2003-04-10 Elan Pharmaceuticals, Inc. Hydroxypropylamines
GB0325830D0 (en) * 2003-11-05 2003-12-10 Novartis Ag Organic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002002512A2 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
JP2005520791A (ja) * 2001-11-08 2005-07-14 イーラン ファーマスーティカルズ、インコーポレイテッド Ｎ，ｎ’−置換−１，３−ジアミノ−２−ヒドロキシプロパン誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006508166A (ja) * 2002-11-27 2006-03-09 イーラン ファーマスーティカルズ、インコーポレイテッド 置換尿素及びカルバメート

Also Published As

Publication number Publication date
US7115747B2 (en) 2006-10-03
BR0312439A (pt) 2005-05-10
ATE370131T1 (de) 2007-09-15
EA008389B1 (ru) 2007-04-27
DE60315664D1 (de) 2007-09-27
CN1662510A (zh) 2005-08-31
US20040063965A1 (en) 2004-04-01
CA2489988A1 (en) 2003-12-31
MXPA04012630A (es) 2005-09-30
PL374999A1 (en) 2005-11-14
EA200401510A1 (ru) 2005-06-30
US20070105921A1 (en) 2007-05-10
WO2004000821A1 (en) 2003-12-31
EP1532123A1 (en) 2005-05-25
NZ537390A (en) 2006-07-28
CN1324017C (zh) 2007-07-04
CO5670350A2 (es) 2006-08-31
NO20045497D0 (no) 2004-12-16
IL165763A0 (en) 2006-01-15
EP1532123B1 (en) 2007-08-15
NO20045497L (no) 2005-03-07
AU2003249344A1 (en) 2004-01-06
HK1081543A1 (zh) 2006-05-19

Similar Documents

Publication Publication Date Title
US7115747B2 (en) Process for preparing oxazole intermediates
KR102630720B1 (ko) 벤질 화합물
RU2742005C2 (ru) Способы получения 4-алкокси-3-(ацил или алкил)оксипиколинамидов
KR102421025B1 (ko) 신규 트리틸 보호제
EP2385050A1 (en) A process for preparing a substituted oxazole
KR20020033617A (ko) 2,2-디메틸-1,3-디옥산 중간체의 염 및 그것의 제조방법
WO2006104166A1 (ja) 晶析分離用担体及び化合物の分離方法
JP5121232B2 (ja) インドールのｃ−３位を還元的アルキル化するための合成方法
WO2008090046A1 (en) Alternate process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone
KR20080072738A (ko) 아미도-페녹시벤조산 화합물의 제조를 위한 화학적 방법
CN117362316A (zh) 一种四氢吡咯并噻唑类化合物的合成方法
KR20050019766A (ko) 5-(1,3-옥사졸-2-일)벤조산 유도체의 제조 방법
KR102942439B1 (ko) 치환된 아크릴레이트 화합물의 제조
JP2022035954A (ja) Ｎ－Ｂｏｃ－ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法
HK1081543B (en) Process for preparing 5-(1,3-oxazol-2-yl) benzoic acid derivatives
JPH0577670B2 (cg-RX-API-DMAC7.html)
JPH0347269B2 (cg-RX-API-DMAC7.html)
JPH06220052A (ja) イミド誘導体の製造法
JP2703048B2 (ja) プロリン誘導体の製法
JPH0641066A (ja) ピロール誘導体の製造方法
HK40110664A (zh) 7，8-二氢-2h-环戊二烯并吡咯并吡嗪酮化合物的合成方法
HK40110664B (en) Synthesis method for 7,8-dihydro-2h-cyclopentapyrrolopyrazinone compound
JPH0670024B2 (ja) グルタコン酸エステル誘導体の製法
JP2007320930A (ja) フェニルテトラゾール誘導体の製造法
JPH0414114B2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060530

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060530

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091204

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100423